These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7062468)
21. Biliary contrast agents: comparative study about the binding to human plasma and the effect of human plasma on hepatic uptake. Müller WE; Stillbauer AE Pharmacology; 1981; 22(4):269-75. PubMed ID: 7267698 [TBL] [Abstract][Full Text] [Related]
22. Current trends in excretion urography. Butler JP Radiography; 1970 Apr; 36(424):75-9. PubMed ID: 5433243 [No Abstract] [Full Text] [Related]
23. [Biliary excretion kinetics of the biliary contrast media ioglycamide, iodoxamate and iotroxamate in the dog]. Zaunbauer W; Grandjean EM; Paumgartner G; Fuchs WA Schweiz Med Wochenschr; 1981 Jan; 111(5):157-61. PubMed ID: 6895123 [TBL] [Abstract][Full Text] [Related]
24. Excretion urography. I. Factors determining the excretion of Hypaque. Cattell WR; Fry IK; Spencer AG; Purkiss P Br J Radiol; 1967 Aug; 40(476):561-71. PubMed ID: 4952292 [No Abstract] [Full Text] [Related]
26. Vicarious excretion of intravascular contrast material. Barry WF; Forbis SE J Urol; 1968 Nov; 100(5):704. PubMed ID: 5682553 [No Abstract] [Full Text] [Related]
27. Pharmacokinetics of a hepatotropic and a renotropic x-ray contrast agent under haemodialysis. Siemensen HC; Augustin HJ Int Urol Nephrol; 1973 Apr; 5(2):195-204. PubMed ID: 4774523 [No Abstract] [Full Text] [Related]
28. [Heterotopic contrast media excretion: excretion of bilivistan through the mucous membrane of the stomach and small intestine]. Reinhardt K Fortschr Geb Rontgenstr Nuklearmed; 1967 Feb; 106(2):288-91. PubMed ID: 5626687 [No Abstract] [Full Text] [Related]
29. [Significance of the liver cell in elimination of cholegraphic agents (author's transl)]. Otto H Radiologe; 1980 Jan; 20(1):16-23. PubMed ID: 7360933 [TBL] [Abstract][Full Text] [Related]
30. Extra-renal excretion of contrast material a possible indicator of renal damage. Jancu J; Shapiro G Clin Radiol; 1971 Apr; 22(2):219-21. PubMed ID: 5575260 [No Abstract] [Full Text] [Related]
31. [The relationship between excretion of contrast-medium and timing of radiographs in infusion-urography and different renal function (author's transl)]. Bahlmann JO; Holsten DR Rontgenblatter; 1974 May; 27(5):226-9. PubMed ID: 4838866 [No Abstract] [Full Text] [Related]
32. Vicarious excretion of intravenous diatrizoate (Urograffin) in renal insufficiency: report of two cases. Ogunseyinde AO; Nzeh DA West Afr J Med; 1992; 11(4):304-7. PubMed ID: 1304796 [TBL] [Abstract][Full Text] [Related]
33. [Studies and computer analyses on the kinetics of nephrotropic contrast media in patients with different kidney function]. Baars HG; Weiss M; Schabel J; Rauchfuss J Z Urol Nephrol; 1978 Oct; 71(10):679-83. PubMed ID: 735463 [TBL] [Abstract][Full Text] [Related]
34. Excretion of metrizamide. I. Comparison with diatrizoate and iothalamate after intravenous administration in rabbits. Golman K Acta Radiol Suppl; 1973; 335():253-7. PubMed ID: 4534562 [No Abstract] [Full Text] [Related]
35. Renal excretion mechanism of a nonionic contrast agent. Golman K; Wilk I Invest Radiol; 1979; 14(3):224-7. PubMed ID: 468494 [TBL] [Abstract][Full Text] [Related]